First National Bank of Mount Dora’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
First National Bank of Mount Dora's VRTX Position: Q2 2026 in Review
First National Bank of Mount Dora reduced its Vertex Pharmaceuticals (VRTX) stake by 0.24% in Q2 2026, selling an estimated $7.53K and leaving 7,194 shares worth $3.57M. The position accounts for 0.72% of the portfolio, ranked #49.
First National Bank of Mount Dora first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.52M in Q3 2024. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- First National Bank of Mount Dora held 7,194 shares of Vertex Pharmaceuticals worth $3.57M as of Q2 2026.
- First National Bank of Mount Dora sold 17 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
- Vertex Pharmaceuticals made up 0.72% of First National Bank of Mount Dora's portfolio in Q2 2026, its #49 holding.
- First National Bank of Mount Dora first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
- First National Bank of Mount Dora's Vertex Pharmaceuticals position peaked at $5.52M in Q3 2024.
- 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on First National Bank of Mount Dora's 13F filing for Q2 2026, filed 8 Jul 2026.